 | • レポートコード：MRC2102A042 • 出版社/出版日：Transparency Market Research / 2020年12月17日 • レポート形態：英文、PDF、180ページ • 納品方法：Eメール • 産業分類：包装 |
| Single User（1名様閲覧） | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Site Licence（同一拠点内共有可） | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Enterprisewide Licence（複数拠点内共有可） | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本市場調査レポートでは、世界のアンプルフィルド医薬製品市場について調査・分析し、エグゼクティブサマリー、市場イントロダクション、市場観点、新型コロナウイルス感染症の影響、市場分析、治療別（抗がん剤、抗糖尿病薬、神経薬、心血管薬、鎮痛薬、抗感染薬、ワクチン、その他）分析、医薬品種類別分析、地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ）分析、市場構造分析、競争状況、仮定、調査手法を掲載しています。 ・エグゼクティブサマリー ・市場イントロダクション ・市場観点 ・新型コロナウイルス感染症の影響 ・市場分析 ・世界のアンプルフィルド医薬製品市場規模：治療別（抗がん剤、抗糖尿病薬、神経薬、心血管薬、鎮痛薬、抗感染薬、ワクチン、その他） ・世界のアンプルフィルド医薬製品市場規模：医薬品種類別 ・世界のアンプルフィルド医薬製品市場規模：地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ） ・市場構造分析 ・競争状況 ・仮定 ・調査手法 |
Ampoule Filled Pharmaceutical Products Market – Scope of the Report
Transparency Market Research (TMR) started a new study on the global ampoule filled pharmaceutical products market, providing forecast for the period of 2020-2030. In the study, growth opportunity for the ampoule filled pharmaceutical products market is witnessed. The report provides valuable insights, which enable readers to make winning business decisions for future growth of their businesses. The report highlights significant factors that are constantly determining the growth of the ampoule filled pharmaceutical products market, untapped opportunities for manufacturers, trends and developments, and other insights across various key segments. Macroeconomic factors that are directly or indirectly affecting market growth are also incorporated in the report.
Key Questions Answered in TMR’s Ampoule Filled Pharmaceutical Products Market Report
What will be market size for ampoule filled pharmaceutical products by the end of 2030?
What will be the impact of COVID-19 on ampoule filled pharmaceutical products market?
Which region will remain most lucrative for market growth?
Which drug class holds maximum market share in the global ampoule filled pharmaceutical products market?
Who are major key players in the ampoule filled pharmaceutical products market?
Key indicators associated with the ampoule filled pharmaceutical products market have been calculated thoroughly in the report. The study enumerates vital market dynamics such as key drivers, challenges, and trends, along with opportunities in the global ampoule filled pharmaceutical products market. A comprehensive study on the value chain, which includes component suppliers, manufacturers, distributors, and end users have been incorporated in the global market report. Other key aspects laid down in the market include pricing strategy of leading market players and comparative analysis of ampoule filled pharmaceutical products. Furthermore, forecast factors and forecast scenarios of the ampoule filled pharmaceutical products market have been covered in the report to understand future prospects of the market.
A comprehensive evaluation and forecast on the ampoule filled pharmaceutical products market are provided on the therapeutic area, drug type, and region.
Y-o-Y growth comparison, revenue comparison, and market share comparison of various market segments are provided in the report. The ampoule filled pharmaceutical products market is analyzed at both regional and country levels.
The report delivers an exhaustive assessment on the structure of the ampoule filled pharmaceutical products market, in tandem with a dashboard view of all leading company profiles in the report. Every company’s share analysis on market players have also been presented in the report, apart from the footprint matrix of profiled market players. The report depicts the presence of ampoule filled pharmaceutical products manufacturers by leveraging an intensity map. It also highlights key end users for ampoule filled pharmaceutical products.
The report includes company overview of key players. Some of the key companies profiled in the ampoule filled pharmaceutical products market report include Pfizer Inc, GlaxoSmithKline plc, Sanofi, Roche Holding AG, Novartis AG, Allergan, Johnson & Johnson, Merck, Sun Pharmaceutical Industries Ltd, and Cadila Healthcare.
Research Methodology
A realistic methodology, along with a holistic approach makes the base for sharp insights, which are provided in the ampoule filled pharmaceutical products market for the study evaluation period. The TMR report comprises of detailed information on growth prospects, along with riveting insights into the forecast assessment of the market.
Extensive primary and secondary researches have been employed to garner keen insights into the forecast study of the ampoule filled pharmaceutical products market. The report has further undergone a cross-validation by in-house professionals to make the ampoule filled pharmaceutical products market report one-of-its-kind, with the highest credibility.
レポート目次1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. TMR Analysis and Recommendations
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Market Viewpoint
3.1. Global Economic Outlook
3.2. Global Pharmaceutical Market Overview
3.3. Macro-Economic Factors and Co-relation Analysis
3.4. Forecast Factors – Relevance and Impact
3.5. Value Chain Analysis
3.5.1. Exhaustive List of Active Participants
3.5.1.1. Raw Material Suppliers
3.5.1.2. Manufacturers
3.5.1.3. Distributers/End Users
3.5.2. Profitability Margins
4. Impact of COVID-19
4.1.1. Current Statistics and Probable Future Impact
4.1.2. Current Economic Projection – GDP/GVA and Probable Impact
4.1.3. Comparison of SAARs and Market Recovery, for Key Countries
4.1.4. Comparison to 2008 Financial Crisis and Market Recovery, for Key Countries
4.1.5. Impact of COVID-19 on Ampoule Filled Pharmaceutical Products Market
5. Ampoule Filled Pharmaceutical Products Market Analysis
5.1. Market Value (US$ Bn) and Analysis & Forecast
5.2. Y-o-Y Growth Projections
5.3. Absolute $ Opportunity Analysis
6. Global Ampoule Filled Pharmaceutical Products Analysis and Forecast, By Therapeutic Area
6.1. Section Summary
6.2. Introduction
6.2.1. Market share and Basis Points (BPS) Analysis By Therapeutic Area
6.2.2. Y-o-Y Growth Projections By Therapeutic Area
6.3. Historical Market Size (US$ Bn) Analysis 2015-2019 By Therapeutic Area
6.3.1. Anticancer
6.3.2. Anti-diabetics
6.3.3. Neurological Drugs
6.3.4. Cardiovascular Drugs
6.3.5. Analgesics
6.3.6. Anti- infectives
6.3.7. Vaccines
6.3.8. Others
6.4. Market Size (US$ Bn) Forecast 2020-2030, By Therapeutic Area
6.4.1. Anticancer
6.4.2. Anti-diabetics
6.4.3. Neurological Drugs
6.4.4. Cardiovascular Drugs
6.4.5. Analgesics
6.4.6. Anti- infectives
6.4.7. Vaccines
6.4.8. Others
6.5. Market Attractiveness Analysis By Therapeutic Area
7. Global Ampoule Filled Pharmaceutical Products Analysis and Forecast, By Drug Type
7.1. Section Summary
7.2. Introduction
7.2.1. Market share and Basis Points (BPS) Analysis By Drug Type
7.2.2. Y-o-Y Growth Projections By Drug Type
7.3. Historical Market Size (US$ Bn) Analysis 2015-2019 By Drug Type
7.3.1. Generic Drugs
7.3.2. Branded Drugs
7.4. Market Size (US$ Bn) Forecast 2020-2030, By Drug Type
7.4.1. Generic Drugs
7.4.2. Branded Drugs
7.5. Market Attractiveness Analysis By Drug Type
8. Global Ampoule Filled Pharmaceutical Products Market Analysis and Forecast, By Region
8.1. Section Summary
8.2. Introduction
8.2.1. Market share and Basis Points (BPS) Analysis By Region
8.2.2. Y-o-Y Growth Projections By Region
8.3. Historical Market Size (US$ Bn) Analysis 2015-2019 By Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Market Size (US$ Bn) Forecast 2020-2030 By Region
8.4.1. North America
8.4.2. Latin America
8.4.3. Europe
8.4.4. Asia Pacific
8.4.5. Middle East and Africa (MEA)
8.5. Market Attractiveness Analysis By Region
9. North America Ampoule Filled Pharmaceutical Products Market Analysis and Forecast
9.1. Section Summary
9.2. Introduction
9.2.1. Market share and Basis Points (BPS) Analysis By Country
9.2.2. Y-o-Y Growth Projections By Country
9.3. Historical Market Size (US$ Bn) Analysis 2015-2019 By Country
9.4. Market Size (US$ Bn) Forecast 2020-2030 By Country
9.4.1. U.S.
9.4.2. Canada
9.5. Historical Market Size (US$ Bn) Analysis 2015-2019 By Therapeutic Area
9.6. Market Size (US$ Bn) Forecast 2020-2030, By Therapeutic Area
9.6.1. Anticancer
9.6.2. Anti-diabetics
9.6.3. Neurological Drugs
9.6.4. Cardiovascular Drugs
9.6.5. Analgesics
9.6.6. Anti- infectives
9.6.7. Vaccines
9.6.8. Others
9.7. Historical Market Size (US$ Bn) Analysis 2015-2019 By Drug Type
9.8. Market Size (US$ Bn) Forecast 2020-2030, By Drug Type
9.8.1. Generic Drugs
9.8.2. Branded Drugs
9.9. Prominent Trends
10. Latin America Ampoule Filled Pharmaceutical Products Market Analysis and Forecast
10.1. Section Summary
10.2. Introduction
10.2.1. Market share and Basis Points (BPS) Analysis By Country
10.2.2. Y-o-Y Growth Projections By Country
10.3. Historical Market Size (US$ Bn) Analysis 2015-2019 By Country
10.4. Market Size (US$ Bn) Forecast 2020-2030 By Country
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Argentina
10.4.4. Rest of Latin America
10.5. Historical Market Size (US$ Bn) Analysis 2015-2019 By Therapeutic Area
10.6. Market Size (US$ Bn) Forecast 2020-2030, By Therapeutic Area
10.6.1. Anticancer
10.6.2. Anti-diabetics
10.6.3. Neurological Drugs
10.6.4. Cardiovascular Drugs
10.6.5. Analgesics
10.6.6. Anti- infectives
10.6.7. Vaccines
10.6.8. Others
10.7. Historical Market Size (US$ Bn) Analysis 2015-2019 By Drug Type
10.8. Market Size (US$ Bn) Forecast 2020-2030, By Drug Type
10.8.1. Generic Drugs
10.8.2. Branded Drugs
10.9. Prominent Trends
11. Europe Ampoule Filled Pharmaceutical Products Market Analysis and Forecast
11.1. Section Summary
11.2. Introduction
11.2.1. Market share and Basis Points (BPS) Analysis By Country
11.2.2. Y-o-Y Growth Projections By Country
11.3. Historical Market Size (US$ Bn) Analysis 2015-2019 By Country
11.4. Market Size (US$ Bn) Forecast 2020-2030 By Country
11.4.1. Germany
11.4.2. Spain
11.4.3. Italy
11.4.4. France
11.4.5. U.K.
11.4.6. BENELUX
11.4.7. NORDIC
11.4.8. Russia
11.4.9. Poland
11.4.10. Rest of Europe
11.5. Historical Market Size (US$ Bn) Analysis 2015-2019 By Therapeutic Area
11.6. Market Size (US$ Bn) Forecast 2020-2030, By Therapeutic Area
11.6.1. Anticancer
11.6.2. Anti-diabetics
11.6.3. Neurological Drugs
11.6.4. Cardiovascular Drugs
11.6.5. Analgesics
11.6.6. Anti- infectives
11.6.7. Vaccines
11.6.8. Others
11.7. Historical Market Size (US$ Bn) Analysis 2015-2019 By Drug Type
11.8. Market Size (US$ Bn) Forecast 2020-2030, By Drug Type
11.8.1. Generic Drugs
11.8.2. Branded Drugs
11.9. Prominent Trends
12. Asia Pacific Ampoule Filled Pharmaceutical Products Market Analysis and Forecast
12.1. Section Summary
12.2. Introduction
12.2.1. Market share and Basis Points (BPS) Analysis By Country
12.2.2. Y-o-Y Growth Projections By Country
12.3. Historical Market Size (US$ Bn) Analysis 2015-2019 By Country
12.4. Market Size (US$ Bn) Forecast 2020-2030 By Country
12.4.1. China
12.4.2. India
12.4.3. Japan
12.4.4. ASEAN
12.4.5. Australia and New Zealand
12.4.6. Rest of APAC
12.5. Historical Market Size (US$ Bn) Analysis 2015-2019 By Therapeutic Area
12.6. Market Size (US$ Bn) Forecast 2020-2030, By Therapeutic Area
12.6.1. Anticancer
12.6.2. Anti-diabetics
12.6.3. Neurological Drugs
12.6.4. Cardiovascular Drugs
12.6.5. Analgesics
12.6.6. Anti- infectives
12.6.7. Vaccines
12.6.8. Others
12.7. Historical Market Size (US$ Bn) Analysis 2015-2019 By Drug Type
12.8. Market Size (US$ Bn) Forecast 2020-2030, By Drug Type
12.8.1. Generic Drugs
12.8.2. Branded Drugs
12.9. Prominent Trends
13. Middle East and Africa Ampoule Filled Pharmaceutical Products Market Analysis and Forecast
13.1. Section Summary
13.2. Introduction
13.2.1. Market share and Basis Points (BPS) Analysis By Country
13.2.2. Y-o-Y Growth Projections By Country
13.3. Historical Market Size (US$ Bn) Analysis 2015-2019 By Country
13.4. Market Size (US$ Bn) Forecast 2020-2030 By Country
13.4.1. GCC countries
13.4.2. Northern Africa
13.4.3. South Africa
13.4.4. Turkey
13.4.5. Rest of MEA
13.5. Historical Market Size (US$ Bn) Analysis 2015-2019 By Therapeutic Area
13.6. Market Size (US$ Bn) Forecast 2020-2030, By Therapeutic Area
13.6.1. Anticancer
13.6.2. Anti-diabetics
13.6.3. Neurological Drugs
13.6.4. Cardiovascular Drugs
13.6.5. Analgesics
13.6.6. Anti- infectives
13.6.7. Vaccines
13.6.8. Others
13.7. Historical Market Size (US$ Bn) Analysis 2015-2019 By Drug Type
13.8. Market Size (US$ Bn) Forecast 2020-2030, By Drug Type
13.8.1. Generic Drugs
13.8.2. Branded Drugs
13.9. Prominent Trends
14. Market Structure Analysis
14.1. Market Analysis, by Tier of Companies
14.2. Market Concentration
14.3. Market Presence Analysis
15. Competitive Landscape
15.1. Competition Dashboard
15.2. Company Market Share Analysis
15.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments, SWOT analysis)
15.4. Competition Deep Dive
15.4.1.1. Pfizer Inc
15.4.1.1.1. Overview
15.4.1.1.2. Product Portfolio
15.4.1.1.3. Profitability
15.4.1.1.4. Sales Footprint
15.4.1.1.5. Competition Benchmarking
15.4.1.1.6. Strategy
15.4.1.1.6.1. Marketing Strategy
15.4.1.1.6.2. Product Strategy
15.4.1.1.6.3. Channel Strategy
15.4.1.2. GlaxoSmithKline plc
15.4.1.2.1. Overview
15.4.1.2.2. Product Portfolio
15.4.1.2.3. Profitability
15.4.1.2.4. Sales Footprint
15.4.1.2.5. Competition Benchmarking
15.4.1.2.6. Strategy
15.4.1.2.6.1. Marketing Strategy
15.4.1.2.6.2. Product Strategy
15.4.1.2.6.3. Channel Strategy
15.4.1.3. Sanofi
15.4.1.3.1. Overview
15.4.1.3.2. Product Portfolio
15.4.1.3.3. Profitability
15.4.1.3.4. Sales Footprint
15.4.1.3.5. Competition Benchmarking
15.4.1.3.6. Strategy
15.4.1.3.6.1. Marketing Strategy
15.4.1.3.6.2. Product Strategy
15.4.1.3.6.3. Channel Strategy
15.4.1.4. Roche Holding AG
15.4.1.4.1. Overview
15.4.1.4.2. Product Portfolio
15.4.1.4.3. Profitability
15.4.1.4.4. Sales Footprint
15.4.1.4.5. Competition Benchmarking
15.4.1.4.6. Strategy
15.4.1.4.6.1. Marketing Strategy
15.4.1.4.6.2. Product Strategy
15.4.1.4.6.3. Channel Strategy
15.4.1.5. Novartis AG
15.4.1.5.1. Overview
15.4.1.5.2. Product Portfolio
15.4.1.5.3. Profitability
15.4.1.5.4. Sales Footprint
15.4.1.5.5. Competition Benchmarking
15.4.1.5.6. Strategy
15.4.1.5.6.1. Marketing Strategy
15.4.1.5.6.2. Product Strategy
15.4.1.5.6.3. Channel Strategy
15.4.1.6. Allergan
15.4.1.6.1. Overview
15.4.1.6.2. Product Portfolio
15.4.1.6.3. Profitability
15.4.1.6.4. Sales Footprint
15.4.1.6.5. Competition Benchmarking
15.4.1.6.6. Strategy
15.4.1.6.6.1. Marketing Strategy
15.4.1.6.6.2. Product Strategy
15.4.1.6.6.3. Channel Strategy
15.4.1.7. Johnson & Johnson
15.4.1.7.1. Overview
15.4.1.7.2. Product Portfolio
15.4.1.7.3. Profitability
15.4.1.7.4. Sales Footprint
15.4.1.7.5. Competition Benchmarking
15.4.1.7.6. Strategy
15.4.1.7.6.1. Marketing Strategy
15.4.1.7.6.2. Product Strategy
15.4.1.7.6.3. Channel Strategy
15.4.1.8. Merck
15.4.1.8.1. Overview
15.4.1.8.2. Product Portfolio
15.4.1.8.3. Profitability
15.4.1.8.4. Sales Footprint
15.4.1.8.5. Competition Benchmarking
15.4.1.8.6. Strategy
15.4.1.8.6.1. Marketing Strategy
15.4.1.8.6.2. Product Strategy
15.4.1.8.6.3. Channel Strategy
15.4.1.9. un Pharmaceutical Industries Ltd
15.4.1.9.1. Overview
15.4.1.9.2. Product Portfolio
15.4.1.9.3. Profitability
15.4.1.9.4. Sales Footprint
15.4.1.9.5. Competition Benchmarking
15.4.1.9.6. Strategy
15.4.1.9.6.1. Marketing Strategy
15.4.1.9.6.2. Product Strategy
15.4.1.9.6.3. Channel Strategy
15.4.1.10. Cadila Healthcare
15.4.1.10.1. Overview
15.4.1.10.2. Product Portfolio
15.4.1.10.3. Profitability
15.4.1.10.4. Sales Footprint
15.4.1.10.5. Competition Benchmarking
15.4.1.10.6. Strategy
15.4.1.10.6.1. Marketing Strategy
15.4.1.10.6.2. Product Strategy
15.4.1.10.6.3. Channel Strategy
16. Assumptions and Acronyms
17. Research Methodology
List of TablesTable 01: Global Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Therapeutic Area
Table 02: Global Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type
Table 03: Global Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Region
Table 04: North America Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Therapeutic Area
Table 05: North America Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type
Table 06: North America Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country
Table 07: Latin America Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Therapeutic Area
Table 08: Latin America Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type
Table 09: Latin America Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country
Table 10: Europe Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Therapeutic Area
Table 11: Europe Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type
Table 12: Europe Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country
Table 13: Asia Pacific Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Therapeutic Area
Table 14: Asia Pacific Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type
Table 15: Asia Pacific Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country
Table 16: MEA Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Therapeutic Area
Table 17: MEA Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type
Table 18: MEA Ampoule Filled Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country